Levmetamfetamine
As of the edition of 20 October 2026, Levmetamfetamine is a small molecule: of no established status; acts on TAAR1.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Status not established
- Kind
- Small molecule
- Registered trials
- 2, 0 stopped early
- Disease areas
- Ear, nose and throat; Lungs and airways
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| TAAR1 | Trace amine-associated receptor 1 | Q96RJ0 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 1 | 1 | 0 | 0 |
| Phase 1 | 1 | 0 | 1 | 0 |
| All trials | 2 |